Clinical Trials in San Diego

Showing 10541-10560 of 12,589 trials

Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine

NCT01442675

The purpose of this trial is to describe the safety and antibody response to revaccination with Menactra vaccine in persons who received their first dose at ≥11 years of age. Primary Objective: \- To evaluate the antibody responses to meningococcal serogroups A, C, Y, and W-135, measured by serum bactericidal assay using human complement (SBA-HC), induced by Menactra vaccine in subjects who were first vaccinated with Menactra 4-6 years ago. Secondary Objective: \- To evaluate the antibody responses to serogroups A, C, Y, and W-135 in serum specimens collected 6 days post-vaccination in a subset of study population. Observational Objective: \- To describe the rates of immediate reactions, solicited injection-site and systemic reactions, unsolicited adverse events and serious adverse events following vaccination.

MeningitisMeningococcal Infection

Sanofi Pasteur, a Sanofi Company834 participantsStarted Sep 2011

Little Rock, Arkansas, United States • San Diego, California, United States • Bardstown, Kentucky, United States +12 more locations

COMPLETEDNA< 1 mile

Community Implementation of KEEP: Fidelity and Generalization of Parenting

NCT00980512

The primary goal of this study is to examine the fidelity and generalization of parenting effects of the KEEP foster parent training intervention as it is being delivered within a child welfare system of care by a community mental health provider.

Behavior Problems

San Diego State University354 participantsStarted Sep 2009

San Diego, California, United States

Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine

Community Implementation of KEEP: Fidelity and Generalization of Parenting

Find Trials by Condition in San Diego

A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus

Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients

Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)

Gabapentin Treatment of Alcohol Dependence

Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin

Maraviroc in Rheumatoid Arthritis

Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers

Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Argatroban Stroke Treatment - A Pilot Safety Study

Registry of AngioJet Use in the Peripheral Vascular System

An Exploratory Genetic Study in Participants With Psoriasis

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)

An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough

Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma